Гипергрелинемия при синдроме Прадера-Вилли

Изучена пре- и постпрандиальная секреция грелина у детей с синдромом Прадера-Вилли (СПВ). В статье представлены результаты клинического и гормонально-метаболического исследования 17 препубертатных детей с генетически подтвержденным диагнозом СПВ, 15 больных с экзогенно-конституциональным ожирением и 10 здоровых детей. У пациентов с СПВ выявлена пре- и постпрандиальная гипергрелинемия.

синдром Прадера-Вилли, грелин, гиперфагия, ожирение

1. Wattendorf DJ, Muenke M. Prader-Willi syndrome. American Family Physician Journal 2005;72(5):827-830.

2. Yearwood EL, Mc Culloch MR, Tucker ML, Riley JB. Care of the patient with Prader-Willi syndrome. Medsurg Nursing: The Journal of Adult Health 2011;20(3):113-122.

3. Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the Diagnosis and Management of Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2008;93(11):4183-4197. doi: 10.1210/jc.2008-0649

4. Ho AY, Dimitropoulos A. Clinical management of behavioral characteristics of Prader-Willi syndrome. Journal of Neuropsychiatric Disease and Treatment 2010;6:107-18. doi: 10.2147/NDT.S5560

5. Chen C, Visootsak J, Dills S, Graham JM. Prader-Willi Syndrome: An Update and Review for the Primary Pediatrician. Clinical Pediatrics. 2007;46(7):580-591. doi: 10.1177/0009922807299314

6. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The Changing Purpose of Prader-Willi Syndrome Clinical Diagnostic Criteria and Proposed Revised Criteria. Pediatrics. 2001;108(5):e92-e92. doi: 10.1542/peds.108.5.e92

7. Erdie-Lalena CR, Holm VA, Kelly PC, Frayo RS, Cummings DE. Ghrelin levels in young children with Prader-Willi syndrome. The Journal of Pediatrics. 2006;149(2):199-204. doi: 10.1016/j.jpeds.2006.04.011

8. Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold J-A, Kimonis V, et al. Nutritional phases in Prader-Willi syndrome. American Journal of Medical Genetics Part A. 2011;155(5):1040-1049. doi: 10.1002/ajmg.a.33951

9. Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. International Journal of Obesity. 2012;36(12):1564-1570. doi: 10.1038/ijo.2011.274

10. Choe YH, Song SY, Paik K-H, Oh YJ, Chu S-H, Yeo SH, et al. Increased Density of Ghrelin-Expressing Cells in the Gastric Fundus and Body in Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2005;90(9):5441-5445. doi: 10.1210/jc.2004-1935

11. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, et al. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clinical Endocrinology. 2008;69(6):911-920. doi: 10.1111/j.1365-2265.2008.03385.x

12. Paik K-H, Lee M-K, Jin D-K, Kang HW, Lee KH, Kim AH, et al. Marked Suppression of Ghrelin Concentration by Insulin in Prader-Willi Syndrome. Journal of Korean Medical Science. 2007;22(2):177. doi: 10.3346/jkms.2007.22.2.177

13. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Nature. 1999;402(6762):656-660. doi: 10.1038/45230

14. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, et al. Ghrelin, a Novel Growth Hormone-Releasing Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell Type in the Gastrointestinal Tracts of Rats and Humans1. Endocrinology. 2000;141(11):4255-4261. doi: 10.1210/endo.141.11.7757

15. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans. Diabetes. 2001;50(8):1714-1719. doi: 10.2337/diabetes.50.8.1714

16. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. Stomach Is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in Humans. The Journal of Clinical Endocrinology & Metabolism. 2001;86(10):4753-4758. doi: 10.1210/jcem.86.10.7885

17. Giménez-Palop O, Giménez-Pérez G, Mauricio D, González-Clemente J-M, Potau N, Berlanga E, et al. A lesser postprandial suppression of plasma ghrelin in Prader?Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clinical Endocrinology. 2007;66(2):198-204. doi: 10.1111/j.1365-2265.2006.02707.x

18. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, et al. Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3–36Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma. The Journal of Clinical Endocrinology & Metabolism. 2005;90(5):2681-2690. doi: 10.1210/jc.2003-032209

19. Maintenance of a Normal Meal-induced Decrease in Plasma Ghrelin Levels in Children with Prader-Willi Syndrome. Hormone and Metabolic Research. 2004;36(3):164-169. doi: 10.1055/s-2004-814340

20. Cole TJ. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240-1240. doi: 10.1136/bmj.320.7244.1240

21. Speiser PW, Rudolf MCJ, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, et al. Childhood Obesity. The Journal of Clinical Endocrinology & Metabolism. 2005;90(3):1871-1887. doi: 10.1210/jc.2004-1389

22. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents. Pediatrics. 2005;115(4):e500-e503. doi: 10.1542/peds.2004-1921

23. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Nature. 1999;402(6762):656-660. doi: 10.1038/45230

24. Kojima M. Ghrelin: Structure and Function. Physiological Reviews. 2005;85(2):495-522. doi: 10.1152/physrev.00012.2004

25. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans. Diabetes. 2001;50(8):1714-1719. doi: 10.2337/diabetes.50.8.1714

26. van der Lely AJ, Tschöp M, Heiman ML, Ghigo E. Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin. Endocrine Reviews. 2004;25(3):426-457. doi: 10.1210/er.2002-0029

27. Guan HZ, Li QC, Jiang ZY. Ghrelin acts on rat dorsal vagal complex to stimulate feeding via arcuate neuropeptide Y/agouti-related peptide neurons activation. Sheng Li Xue Bao 2010;62(4):357–364.

28. Egecioglu E, Stenström B, Pinnock SB, Tung LYC, Dornonville de la Cour C, Lindqvist A, et al. Hypothalamic gene expression following ghrelin therapy to gastrectomized rodents. Regulatory Peptides. 2008;146(1-3):176-182. doi: 10.1016/j.regpep.2007.09.006

29. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends in Pharmacological Sciences. 2004;25(3):113-117. doi: 10.1016/j.tips.2004.01.010

30. Wiedmer P, Nogueiras R, Broglio F, D'Alessio D, Tschöp MH. Ghrelin, obesity and diabetes. Nature Clinical Practice Endocrinology & Metabolism. 2007;3(10):705-712. doi: 10.1038/ncpendmet0625

31. Patel AD, Stanley SA, Murphy KG, Frost GS, Gardiner JV, Kent AS, et al. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regulatory Peptides. 2006;134(1):17-22. doi: 10.1016/j.regpep.2005.11.001

32. Atalayer D, Gibson C, Konopacka A, Geliebter A. Ghrelin and eating disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013;40:70-82. doi: 10.1016/j.pnpbp.2012.08.011

33. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, et al. Elevated plasma ghrelin levels in Prader–Willi syndrome. Nature Medicine. 2002;8(7):643-644. doi: 10.1038/nm0702-643

34. Butler MG, Bittel DC, Talebizadeh Z. Plasma Peptide YY and Ghrelin Levels in Infants and Children with Prader-Willi Syndrome. Journal of Pediatric Endocrinology and Metabolism. 2004;17(9). doi: 10.1515/jpem.2004.17.9.1177

35. DelParigi A, Tschöp M, Heiman ML, Salbe AD, Vozarova B, Sell SM, et al. High Circulating Ghrelin: A Potential Cause for Hyperphagia and Obesity in Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2002;87(12):5461-5464. doi: 10.1210/jc.2002-020871

36. Tauber M, eacute, Conte Auriol F, ccedil, oise, Moulin P, et al. Hyperghrelinemia Is a Common Feature of Prader-Willi Syndrome and Pituitary Stalk Interruption: A Pathophysiological Hypothesis. Hormone Research. 2004;62(1):49-54. doi: 10.1159/000078862

37. Paik KH, Jin DK, Song SY, Lee JE, Ko SH, Song SM, et al. Correlation between Fasting Plasma Ghrelin Levels and Age, Body Mass Index (BMI), BMI Percentiles, and 24-Hour Plasma Ghrelin Profiles in Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2004;89(8):3885-3889. doi: 10.1210/jc.2003-032137

38. Purtell L, Sze L, Loughnan G, Smith E, Herzog H, Sainsbury A, et al. In adults with Prader–Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels. Neuropeptides. 2011;45(4):301-307. doi: 10.1016/j.npep.2011.06.001

39. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, et al. Fasting and Postprandial Hyperghrelinemia in Prader-Willi Syndrome Is Partially Explained by Hypoinsulinemia, and Is Not Due to Peptide YY3–36Deficiency or Seen in Hypothalamic Obesity Due to Craniopharyngioma. The Journal of Clinical Endocrinology & Metabolism. 2005;90(5):2681-2690. doi: 10.1210/jc.2003-032209

40. Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The Metabolic Phenotype of Prader-Willi Syndrome (PWS) in Childhood: Heightened Insulin Sensitivity Relative to Body Mass Index. The Journal of Clinical Endocrinology & Metabolism. 2011;96(1):E225-E232. doi: 10.1210/jc.2010-1733

41. Zou C-C. Factors associated with fasting plasma ghrelin levels in children and adolescents. World Journal of Gastroenterology. 2008;14(5):790. doi: 10.3748/wjg.14.790

42. Litwack, G, Begley T, Means A, O'Malley B, Riddiford L, Tashjian JA. Vitamins and Hormones: Ghrelin. Vitamins and Hormones. Oxford, UK: Elsevier Press; 2008.

43. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, et al. Visceral Adipose Tissue and Metabolic Complications of Obesity Are Reduced in Prader-Willi Syndrome Female Adults: Evidence for Novel Influences on Body Fat Distribution. The Journal of Clinical Endocrinology & Metabolism. 2001;86(9):4330-4338. doi: 10.1210/jcem.86.9.7814

44. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, Butler MG. Circulating adiponectin levels, body composition and obesity-related variables in Prader–Willi syndrome: comparison with obese subjects. International Journal of Obesity. 2005;30(2):382-387. doi: 10.1038/sj.ijo.0803115

45. Kempa A, Krzyzanowska-Świniarska B, Miazgowski T, Pilarska K. Not insulin but insulin sensivity, leptin, and Cortisol are major factors regulating serum acylated ghrelin level in healthy women. Journal of Endocrinological Investigation. 2014;30(8):659-665. doi: 10.1007/bf03347446

46. Purnell JQ, Weigle DS, Breen P, Cummings DE. Ghrelin Levels Correlate with Insulin Levels, Insulin Resistance, and High-Density Lipoprotein Cholesterol, But Not with Gender, Menopausal Status, or Cortisol Levels in Humans. The Journal of Clinical Endocrinology & Metabolism. 2003;88(12):5747-5752. doi: 10.1210/jc.2003-030513

47. Hagemann D, Holst JJ, Gethmann A, Banasch M, Schmidt WE, Meier JJ. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. Regulatory Peptides. 2007;143(1-3):64-68. doi: 10.1016/j.regpep.2007.03.002

48. Ukkola O. Ghrelin and Metabolic Disorders. Current Protein & Peptide Science. 2009;10(1):2-7. doi: 10.2174/138920309787315220

49. Salehi A. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regulatory Peptides. 2004;118(3):143-150. doi: 10.1016/j.regpep.2003.12.001

50. Salehi A. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice. Regulatory Peptides. 2004;118(3):143-150. doi: 10.1016/j.regpep.2003.12.001

51. Heppner KM, Tong J, Kirchner H, Nass R, Tschöp MH. The ghrelin O-acyltransferase–ghrelin system: a novel regulator of glucose metabolism. Current Opinion in Endocrinology, Diabetes and Obesity. 2011;18(1):50-55. doi: 10.1097/MED.0b013e328341e1d3

52. Qi X, Reed J, Englander EW, Chandrashekar V, Bartke A, Greeley GH Jr. Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. Exp Biol Med (Maywood) 2003;228(9):1028–1032.

53. Tan TMM, Vanderpump M, Khoo B, Patterson M, Ghatei MA, Goldstone AP. Somatostatin Infusion Lowers Plasma Ghrelin without Reducing Appetite in Adults with Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2004;89(8):4162-4165. doi: 10.1210/jc.2004-0835

54. De Waele K, Ishkanian SL, Bogarin R, Miranda CA, Ghatei MA, Bloom SR, et al. Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. European Journal of Endocrinology. 2008;159(4):381-388. doi: 10.1530/eje-08-0462

55. Senda M, Ogawa S, Nako K, Okamura M, Sakamoto T, Ito S. The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. Endocrine Journal. 2012;59(10):889-894. doi: 10.1507/endocrj.EJ12-0074